Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Vogel

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Cancer Immunity|August 25, 2007
Expression of cancer-testis (CT) antigens in placentaAchim A Jungbluth, Wilson A Silva, Kristin Iversen, et al.
The Journal of Antimicrobial Chemotherapy|March 6, 2010
Daily dosing of tacrolimus in patients treated with HIV-1 therapy containing a ritonavir-boosted protease inhibitor or raltegravirMarkus Bickel, Evrim Anadol, Martin Vogel, et al.
Scandinavian Journal of Infectious Diseases|July 24, 2013
HIV-associated lung cancer: survival in an unselected cohortChristian Hoffmann, Fabienne Kohrs, Michael Sabranski, et al.
Blood|July 23, 2011
Improved outcome with rituximab in patients with HIV-associated multicentric Castleman diseaseChristian Hoffmann, Holger Schmid, Markus Müller, et al.
Infection|October 21, 2015
Dual treatment of acute HCV infection in HIV co-infection: influence of HCV genotype upon treatment outcomeChristoph Boesecke, Patrick Ingiliz, Thomas Reiberger, et al.
Plos One|August 21, 2012
Hepatitis B surface antigen concentrations in patients with HIV/HBV co-infectionJerzy Jaroszewicz, Thomas Reiberger, Dirk Meyer-Olson, et al.
Antiviral Therapy|November 21, 2007
Pharmacokinetics and pharmacodynamics of combined use of lopinavir/ritonavir and rosuvastatin in HIV-infected patientsManon van der Lee, Raaj Sankatsing, Emile Schippers, et al.
Clinical Drug Investigation|November 25, 2021
Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 vs Physician's Choice of Therapy in the Long-Term Follow-Up of POLLUX, CASTOR, and EQUULEUS Clinical Trials for the Treatment of Patients with Relapsed or Refractory Multiple MyelomaKatja Weisel, Thomas Martin, Amrita Krishnan, et al.
Antiviral Therapy|February 17, 2007
Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individualsMartin Vogel, Jacob Nattermann, Axel Baumgarten, et al.
European Journal of Haematology|July 16, 2021
Full or intensity-reduced high-dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myelomaChristian Straka, Hans Salwender, Stefan Knop, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Cancer Immunity|August 25, 2007
Expression of cancer-testis (CT) antigens in placentaAchim A Jungbluth, Wilson A Silva, Kristin Iversen, et al.
The Journal of Antimicrobial Chemotherapy|March 6, 2010
Daily dosing of tacrolimus in patients treated with HIV-1 therapy containing a ritonavir-boosted protease inhibitor or raltegravirMarkus Bickel, Evrim Anadol, Martin Vogel, et al.
Scandinavian Journal of Infectious Diseases|July 24, 2013
HIV-associated lung cancer: survival in an unselected cohortChristian Hoffmann, Fabienne Kohrs, Michael Sabranski, et al.
Blood|July 23, 2011
Improved outcome with rituximab in patients with HIV-associated multicentric Castleman diseaseChristian Hoffmann, Holger Schmid, Markus Müller, et al.
Infection|October 21, 2015
Dual treatment of acute HCV infection in HIV co-infection: influence of HCV genotype upon treatment outcomeChristoph Boesecke, Patrick Ingiliz, Thomas Reiberger, et al.
Plos One|August 21, 2012
Hepatitis B surface antigen concentrations in patients with HIV/HBV co-infectionJerzy Jaroszewicz, Thomas Reiberger, Dirk Meyer-Olson, et al.
Antiviral Therapy|November 21, 2007
Pharmacokinetics and pharmacodynamics of combined use of lopinavir/ritonavir and rosuvastatin in HIV-infected patientsManon van der Lee, Raaj Sankatsing, Emile Schippers, et al.
Clinical Drug Investigation|November 25, 2021
Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 vs Physician's Choice of Therapy in the Long-Term Follow-Up of POLLUX, CASTOR, and EQUULEUS Clinical Trials for the Treatment of Patients with Relapsed or Refractory Multiple MyelomaKatja Weisel, Thomas Martin, Amrita Krishnan, et al.
Antiviral Therapy|February 17, 2007
Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individualsMartin Vogel, Jacob Nattermann, Axel Baumgarten, et al.
European Journal of Haematology|July 16, 2021
Full or intensity-reduced high-dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myelomaChristian Straka, Hans Salwender, Stefan Knop, et al.
Pageof 12